Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications
Clinical trial NCT01107886 · COMPLETED
Trial details
- NCT number
- NCT01107886
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2013-05-01
- Enrollment
- 18206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.